An Evaluation Of Rigel Pharmaceuticals (NASDAQ: RIGL) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

RIGL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Rigel Pharmaceuticals is $268.33M. A total of 2.81 million shares were traded on the day, compared to an average of 1.03M shares.

In the most recent transaction, RODRIGUEZ RAUL R sold 30,545 shares of RIGL for 1.14 per share on Feb 05 ’24. After the transaction, the CEO, President now owns 2,036,629 company shares. In a previous transaction on Feb 05 ’24, Santos David A sold 8,918 shares at 1.14 per share. RIGL shares that EVP, Chief Commercial Officer owns now total 349,093.

Among the insiders who sold shares, Schorno Dean L disposed of 7,027 shares on Feb 05 ’24 at a per-share price of $1.14. This resulted in the EVP & Chief Financial Officer holding 402,891 shares of RIGL after the transaction. In another insider transaction, RODRIGUEZ RAUL R sold 22,349 shares at $1.13 per share on Feb 02 ’24. Company shares held by the CEO, President now total 2,067,174.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, RIGL has a high of $1.96 and a low of $0.71.

As of this writing, RIGL has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.05. The company reported an EPS of -$0.03 in the last quarter, which was 57.10% higher than expectations of -$0.07.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RIGL’s latest balance sheet shows that the firm has $124.97M in Cash & Short Term Investments as of fiscal 2021. There were $30.57M in debt and $63.55M in liabilities at the time. Its Book Value Per Share was -$0.16, while its Total Shareholder’s Equity was $30.37M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RIGL is Buy with a score of 3.80.

Most Popular

Related Posts